Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at CHF 16.6B, ahead of Merck & Co (CHF 12.3B) and Novartis (CHF 9.6B). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCHF 16.6B
- Median
- CHF 483.3M
- Combined market value
- CHF 4.28T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CHF 16.6B | CHF 555.8B | CHF 230.87 | 1.75% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | CHF 12.3B | CHF 287.6B | CHF 116.65 | 3.49% down | 51% up | ||
| 3 | NovartisNVS · Health Care | CHF 9.6B | CHF 247.3B | CHF 130.95 | 2.39% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | CHF 8.6B | CHF 103.3B | CHF 50.55 | 2.27% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CHF 7.2B | CHF 153.3B | CHF 88.54 | 0.29% up | 17% down | ||
| 6 | SanofiSNY · Health Care | CHF 7.2B | CHF 95.5B | CHF 39.79 | 0.72% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | CHF 6.1B | CHF 1.04T | CHF 1,170.19 | 1.95% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | CHF 4.8B | CHF 234.2B | CHF 151.02 | 1.73% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | CHF 4.4B | CHF 427.3B | CHF 241.71 | 2.09% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | CHF 4.3B | CHF 115.3B | CHF 454.57 | 0.93% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | CHF 3.8B | CHF 38.9B | CHF 340.73 | 2.21% down | 17% up | ||
| 12 | GSKGSK · Health Care | CHF 3.8B | CHF 82.4B | CHF 41.09 | 1.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CHF 3.3B | CHF 146.6B | CHF 33.27 | 3.03% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | CHF 3.1B | CHF 57.3B | CHF 17.95 | 1.64% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 3B | CHF 41.4B | CHF 35.51 | 1.18% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | CHF 2.6B | CHF 82.6B | CHF 798.77 | 1.08% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | CHF 1.9B | CHF 29.6B | CHF 72.96 | 3.67% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | CHF 1.4B | CHF 26.6B | CHF 43.18 | 1.44% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | CHF 1.4B | CHF 16.9B | CHF 126.32 | 4.27% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | CHF 1.3B | CHF 20.8B | CHF 488.96 | 0.71% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | CHF 1.2B | CHF 23.6B | CHF 32.61 | 0.08% down | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 1.2B | CHF 13.3B | CHF 207.59 | 2.29% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | CHF 1.1B | CHF 19.7B | CHF 17.21 | 0.20% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.1B | CHF 10B | CHF 51.77 | 4.95% up | 11% up | ||
| 25 | PfizerPFE · Health Care | CHF 962.8M | CHF 135.2B | CHF 23.72 | 1.18% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | CHF 830.2M | CHF 4.2B | CHF 50.72 | 0.34% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | CHF 771.7M | CHF 4.9B | CHF 7.13 | 2.03% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | CHF 760.4M | CHF 2.7B | CHF 13.69 | 0.81% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | CHF 576.3M | CHF 15B | CHF 228.48 | 0.07% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | CHF 521.6M | CHF 33.4B | CHF 58.14 | 0.41% up | 78% up | ||
| 31 | ABIVAXABVX · Health Care | CHF 483.3M | CHF 6.2B | CHF 70.45 | 1.78% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | CHF 480.7M | CHF 12.8B | CHF 65.64 | 1.38% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | CHF 459.5M | CHF 11.3B | CHF 22.68 | 4.04% up | 20% up | ||
| 34 | InsmedINSM · Health Care | CHF 430.4M | CHF 22.2B | CHF 101.06 | 1.63% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | CHF 327.6M | CHF 6.6B | CHF 39.27 | 2.49% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | CHF 313.9M | CHF 3.9B | CHF 23.47 | 3.26% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | CHF 301.3M | CHF 7.2B | CHF 259.32 | 0.83% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | CHF 297.6M | CHF 5.3B | CHF 131.71 | 0.95% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | CHF 272.3M | CHF 5.9B | CHF 112.95 | 1.46% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | CHF 263.1M | CHF 4.1B | CHF 23.70 | 0.93% up | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | CHF 250.1M | CHF 5.1B | CHF 77.70 | 0.23% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | CHF 237.8M | CHF 6.4B | CHF 18.44 | 3.55% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | CHF 217.4M | CHF 3.3B | CHF 24.42 | 1.41% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 191M | CHF 5.2B | CHF 36.54 | 0.81% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | CHF 189.9M | CHF 7.1B | CHF 8.86 | 1.50% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 167.5M | CHF 7.8B | CHF 334.07 | 6.10% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | CHF 147.5M | CHF 5B | CHF 251.82 | 1.66% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 139.6M | CHF 6.3B | CHF 80.18 | 0.01% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 137.9M | CHF 10.6B | CHF 12.66 | 1.52% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | CHF 108.2M | CHF 7B | CHF 106.84 | 1.65% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | CHF 103.3M | CHF 6.1B | CHF 43.50 | 0.11% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | CHF 101.6M | CHF 6.3B | CHF 57.40 | 2.83% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CHF 78.4M | CHF 4.1B | CHF 42.56 | 1.21% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | CHF 72.3M | CHF 8.1B | CHF 85.03 | 7.50% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | CHF 66.7M | CHF 8.4B | CHF 55.76 | 5.47% up | 107% up | ||
| 56 | ErascaERAS · Health Care | CHF 62.2M | CHF 4.1B | CHF 11.54 | 1.44% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | CHF 51.6M | CHF 3.8B | CHF 35.04 | 1.15% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 45.8M | CHF 6.9B | CHF 100.20 | 1.92% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | CHF 43.1M | CHF 4B | CHF 71.92 | 1.93% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | CHF 39.6M | CHF 5.5B | CHF 80.90 | 0.38% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | CHF 18.4M | CHF 4.4B | CHF 105.11 | 0.77% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8431 CHF).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (CHF 16.6B), Merck & Co (CHF 12.3B) and Novartis (CHF 9.6B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 20:27 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of CHF 4.28T as of 18 Nov 2026, 20:27 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.